NasdaqGS - Nasdaq Real Time Price USD

Outset Medical, Inc. (OM)

Compare
0.6300 +0.0200 (+3.28%)
At close: October 16 at 4:00 PM EDT
Loading Chart for OM
DELL
  • Previous Close 0.6100
  • Open 0.6200
  • Bid 0.6173 x 100
  • Ask 0.6376 x 100
  • Day's Range 0.6101 - 0.6380
  • 52 Week Range 0.4350 - 6.3700
  • Volume 166,627
  • Avg. Volume 1,859,370
  • Market Cap (intraday) 32.817M
  • Beta (5Y Monthly) 1.93
  • PE Ratio (TTM) --
  • EPS (TTM) -3.1400
  • Earnings Date Jan 6, 2025 - Jan 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.15

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

www.outsetmedical.com

480

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OM

View More

Performance Overview: OM

Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OM
88.35%
S&P 500
22.49%

1-Year Return

OM
81.42%
S&P 500
35.00%

3-Year Return

OM
98.71%
S&P 500
30.66%

5-Year Return

OM
98.79%
S&P 500
71.78%

Compare To: OM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OM

View More

Valuation Measures

Annual
As of 10/16/2024
  • Market Cap

    32.82M

  • Enterprise Value

    40.27M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    0.48

  • Enterprise Value/Revenue

    0.35

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -136.72%

  • Return on Assets (ttm)

    -28.98%

  • Return on Equity (ttm)

    -126.48%

  • Revenue (ttm)

    116.42M

  • Net Income Avi to Common (ttm)

    -159.18M

  • Diluted EPS (ttm)

    -3.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    194.85M

  • Total Debt/Equity (mrq)

    294.91%

  • Levered Free Cash Flow (ttm)

    -83.42M

Research Analysis: OM

View More

Company Insights: OM

Research Reports: OM

View More

People Also Watch